Accelerating earlier access to anti-TNF-α agents with biosimilar medicines in the management of inflammatory bowel disease

Authors

Gionata Fiorino, San Camillo-Forlanini Hospital
Ashwin Ananthakrishnan, Massachusetts General Hospital
Russell D Cohen, University of Chicago
Raymond K Cross, The Melissa L. Posner Institute for Digestive Health & Liver Disease
Parakkal Deepak, Washington University School of Medicine in St. Louis
Francis A Farraye, Mayo Clinic Florida
Jonas Halfvarson, Örebro University
A Hillary Steinhart, University of Toronto

Journal

Journal of Clinical Medicine

Publication Date

2-26-2025

Volume

14

Issue

5

First Page

1561

Document Type

Open Access Publication

DOI

10.3390/jcm14051561

Rights and Permissions

Fiorino G, Ananthakrishnan A, Cohen RD, Cross RK, Deepak P, Farraye FA, Halfvarson J, Steinhart AH. Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. J Clin Med. 2025 Feb 26;14(5):1561. doi: 10.3390/jcm14051561 Copyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/).

Recommended Citation

Fiorino, Gionata; Ananthakrishnan, Ashwin; Cohen, Russell D; Cross, Raymond K; Deepak, Parakkal; Farraye, Francis A; Halfvarson, Jonas; and Steinhart, A Hillary, "Accelerating earlier access to anti-TNF-α agents with biosimilar medicines in the management of inflammatory bowel disease." Journal of Clinical Medicine. 14, 5. 1561 (2025).
https://digitalcommons.wustl.edu/oa_4/4926

Department

ICTS (Institute of Clinical and Translational Sciences)